Microbot Medical Inc. Overview
Pro stress-test →Microbot Medical is a breakthrough medical device company focused on transforming endovascular procedures through advanced robotic technology, with its LIBERTY® Endovascular Robotic System representing the first single-use, remotely operated robotic solution designed for precision, efficiency and safety. The company is undergoing a critical transition from a long R&D phase to commercial deployment, with the Limited Market Release commencing in November 2025.
Strategic Profile
Pro stress-test →The company is betting its future on a single-use, remotely operated robotic system to disrupt the $15 billion endovascular surgery market. Microbot has collaboration agreements with Corewell Health for LIBERTY development and Emory University for autonomous robotics in endovascular procedures.
Competitive Landscape
Pro stress-test →Key competitors in the robotic surgery and medical device space include Stereotaxis Inc., Ekso Bionics Holdings, Intuitive Surgical, and other surgical robotics firms. Microbot's single-use, disposable design differentiates it from reusable systems, targeting the underserved peripheral endovascular procedure market.
Industry Context
Microbot Medical Inc. operates in Medical Device - Surgical Robotics.
Key facts
Founded: 2010 · Headquarters: Hingham, Massachusetts · Employees: 21 · Revenue: $0 · Market cap: $140.4M